Milestone Pharmaceuticals Inc. (MIST)

1.04

0.00 (0.00%)

Kompaniya haqida

Milestone Pharmaceuticals Inc., biotexnologiya kompaniyasi, Qo'shma Shtatlar va Kanadada yurak-qon tomir dorilarini ishlab chiqish va tijoratlashtirishga qaratilgan. U kattalarda paroksizmal supraventrikulyar taxikardiya (PSVT) ning o'tkir simptomatik epizodlarini sinus ritmiga aylantirish uchun retsept bo'yicha beriladigan dori vositasi bo'lgan CARDAMYST (etripamil) burun spreyini taklif etadi. Kompaniya, shuningdek, tezkor qorinchali tezlik bilan yurak qorincha fibrilatsiyasi (AFib-RVR) uchun etripamilni ishlab chiqmoqda. U etripamilni ishlab chiqish va tijoratlashtirish bo'yicha Corxel Pharmaceuticals bilan litsenziya va hamkorlik shartnomasiga ega. Milestone Pharmaceuticals Inc. 2003-yilda tashkil etilgan va shtab-kvartirasi Kanadaning Monreali shahrida joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. David B. Bharucha FACC, M.D., Ph.D.	Chief Medical Officer
Dr. Guy Rousseau	SVP of Regulatory Affairs and Quality Management
Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.	Chief Medical Advisor & Member of the Scientific Advisory Board
Dr. Philippe Douville M.B.A., Ph.D.	Founder, Strategic Advisor & Member of Scientific Advisory Board
Mr. Amit Hasija	CFO & Executive VP of Corporate Development
Mr. David Sandoval	General Counsel & Chief Compliance Officer
Mr. Jeff Moore	Vice President of Sales